Kaleido, a recently launched venture by ConsenSys in collaboration with Amazon Web Services, has announced investment and expansion of its Blockchain Business Cloud in the Asia Pacific (APAC) region.

According to the official release, Kaleido is expanding to the AWS data centers in Asia Pacific (Sydney) and Asia Pacific (Seoul) regions, and plans to expand to other regions soon. It would empower APAC businesses to accelerate their transformation through the use of blockchain technology and provide a proven environment with the global scale, security, and qualities of service necessary for production grade blockchain networks.

"Serious investment in enterprise blockchain initiatives across Asia Pacific is off the charts. Building on our partnership and the significant regional presence with AWS, Kaleido and ConsenSys Solutions APAC are meeting this demand and are well poised to scale and grow quickly throughout the region. This is just the beginning, there's much more to come,” Joe Lubin, Co-Founder of Ethereum and CEO of ConsenSys.

Caifeng Gene, a Shanghai-based genomic data sequencing, collection and analytics company, has selected the Kaleido platform to provide a breakthrough permissioned data exchange. It will initially focus on improving early diabetes detection, prevention, and management.

In addition, Caifeng Gene will utilize Kaleido to build a consortium around Diabetes Reference Cohort data as well as patient diagnostic data. The consortium members will include hospitals, genome sequencing service providers, biotech, and pharmaceutical companies. Using blockchain technologies provided by Kaleido, they will be able to securely and efficiently share medical records, lab data, genotype data from microarrays, and DNA data from Next-Generation Sequencing (NGS), in order to develop evidence-based treatment plans tailored to each individual patient, while ensuring personal privacy.

"The goal is to empower individuals to protect, share and monetize their own data and transact with pharma and biotech companies that are looking to harness that data for medical research and development," states Lifeng Tian Ph.D and CEO of Caifeng Gene (Shanghai).

Kaleido is also involved in Project i2i, a Philippine banking consortium aimed at financial inclusion. Project i2i's blockchain-based payment network enabled by the Kaleido platform can reduce the time taken for interbank transactions from up to a month to less than five minutes and eliminates the need for paper-based record keeping and manual transactions.